title: Immune cells in the normal ovary and spontaneous ovarian tumors in the laying hen (Gallus domesticus) model of human ovarian cancer.
abstract: BACKGROUND
  Spontaneous ovarian cancer in chickens resembles human tumors both histologically and biochemically. The goal was to determine if there are differences in lymphocyte content between normal ovaries and ovarian tumors in chickens as a basis for further studies to understand the role of immunity in human ovarian cancer progression.
  
  
  METHODS
  Hens were selected using grey scale and color Doppler ultrasound to determine if they had normal or tumor morphology. Cells were isolated from ovaries (n = 6 hens) and lymphocyte numbers were determined by flow cytometry using antibodies to avian CD4 and CD8 T and B (Bu1a) cells. Ovarian sections from another set of hens (n = 26) were assessed to verify tumor type and stage and to count CD4, CD8 and Bu1a immunostained cells by morphometric analysis.
  
  
  RESULTS
  T and B cells were more numerous in ovarian tumors than in normal ovaries by flow cytometry and immunohistochemistry. There were less CD4+ cells than CD8+ and Bu1a+ cells in normal ovaries or ovarian tumors. CD8+ cells were the dominant T cell sub-type in both ovarian stroma and in ovarian follicles compared to CD4+ cells. Bu1a+ cells were consistently found in the stroma of normal ovaries and ovarian tumors but were not associated with follicles. The number of immune cells was highest in late stage serous tumors compared to endometrioid and mucinous tumors.
  
  
  CONCLUSIONS
  The results suggest that similar to human ovarian cancer there are comparatively more immune cells in chicken ovarian tumors than in normal ovaries, and the highest immune cell content occurs in serous tumors. Thus, this study establishes a foundation for further study of tumor immune responses in a spontaneous model of ovarian cancer which will facilitate studies of the role of immunity in early ovarian cancer progression and use of the hen in pre-clinical vaccine trials.
authors.affiliation: Department of Pharmacology, Rush University Medical Center, Chicago, Illinois, United States of America.
authors.forename: Michael J
authors.initials: MJ
authors.lastname: Bradaric
authors.forename: Krishna
authors.initials: K
authors.lastname: Penumatsa
authors.forename: Animesh
authors.initials: A
authors.lastname: Barua
authors.forename: Seby L
authors.initials: SL
authors.lastname: Edassery
authors.forename: Yi
authors.initials: Y
authors.lastname: Yu
authors.forename: Jacques S
authors.initials: JS
authors.lastname: Abramowicz
authors.forename: Janice M
authors.initials: JM
authors.lastname: Bahr
authors.forename: Judith L
authors.initials: JL
authors.lastname: Luborsky
mesh_terms: D002288:Adenocarcinoma, Mucinous / Q000473:pathology*; D000818:Animals; D001402:B-Lymphocytes / Q000473:pathology*; D015496:CD4-Positive T-Lymphocytes / Q000473:pathology*; D018414:CD8-Positive T-Lymphocytes / Q000473:pathology*; D018267:Carcinoma, Acinar Cell / Q000473:pathology*; D002645:Chickens; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D018655:Lymphocyte Count; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000473:pathology*; D010053:Ovary / Q000473:pathology*
references.citation: Hum Reprod. 1998 Aug;13(8):2186-91
references.pmid: 9756294
references.citation: Am J Clin Pathol. 2006 Mar;125(3):451-8
references.pmid: 16613351
references.citation: Int J Gynecol Cancer. 2009 May;19(4):531-9
references.pmid: 19509547
references.citation: Int Rev Immunol. 2011 Apr-Jun;30(2-3):120-6
references.pmid: 21557638
references.citation: Gen Comp Endocrinol. 1999 Apr;114(1):28-35
references.pmid: 10094856
references.citation: Nat Med. 2004 Sep;10(9):942-9
references.pmid: 15322536
references.citation: Poult Sci. 1998 Sep;77(9):1417-21
references.pmid: 9733132
references.citation: Proc Natl Acad Sci U S A. 2010 Mar 16;107(11):5088-93
references.pmid: 20194765
references.citation: Dev Comp Immunol. 2006;30(1-2):101-18
references.pmid: 16139886
references.citation: Annu Rev Immunol. 1991;9:219-41
references.pmid: 1910677
references.citation: Nature. 1965 Jan 9;205:143-6
references.pmid: 14276257
references.citation: Hum Reprod Update. 2000 Jan-Feb;6(1):1-15
references.pmid: 10711825
references.citation: Cancer Epidemiol Biomarkers Prev. 2008 Sep;17(9):2480-7
references.pmid: 18768519
references.citation: Immunol Rev. 2006 Oct;213:131-45
references.pmid: 16972901
references.citation: Gynecol Oncol. 2008 Feb;108(2):415-20
references.pmid: 18037158
references.citation: Nature. 1999 Oct 28;401(6756):923-5
references.pmid: 10553909
references.citation: Am J Pathol. 1997 May;150(5):1723-34
references.pmid: 9137096
references.citation: J Ultrasound Med. 2010 Feb;29(2):173-82
references.pmid: 20103787
references.citation: Gynecol Oncol. 2008 May;109(2):215-9
references.pmid: 18314181
references.citation: Cancer Immunol Immunother. 2008 Oct;57(10):1531-9
references.pmid: 18343921
references.citation: Gynecol Oncol. 2011 Feb;120(2):256-64
references.pmid: 21093898
references.citation: J Ultrasound Med. 2011 Mar;30(3):333-45
references.pmid: 21357555
references.citation: Int J Gynecol Cancer. 2003 Jul-Aug;13(4):405-12
references.pmid: 12911715
references.citation: J Exp Zool. 1984 Dec;232(3):495-500
references.pmid: 6097631
references.citation: Gynecol Oncol. 2002 Oct;87(1):57-63
references.pmid: 12468343
references.citation: Endocrine. 2008 Jun;33(3):235-44
references.pmid: 18498063
references.citation: J Ovarian Res. 2011 Jul 29;4:12
references.pmid: 21801396
references.citation: Endocrinology. 2010 Sep;151(9):4551-9
references.pmid: 20591976
references.citation: J Reprod Fertil. 1998 Sep;114(1):11-6
references.pmid: 9875150
references.citation: Exp Biol Med (Maywood). 2006 Dec;231(11):1718-25
references.pmid: 17138758
references.citation: Minerva Med. 2009 Oct;100(5):385-400
references.pmid: 19910891
references.citation: Cell. 1989 Oct 6;59(1):171-83
references.pmid: 2507167
references.citation: Gynecol Oncol. 2008 Sep;110(3):418-24
references.pmid: 18606441
references.citation: Immunol Rev. 1999 Feb;167:101-17
references.pmid: 10319254
references.citation: Carcinogenesis. 2009 Jul;30(7):1073-81
references.pmid: 19468060
references.citation: Gynecol Oncol. 2008 Apr;109(1):115-21
references.pmid: 18272210
references.citation: Int J Gynecol Cancer. 2009 May;19(4):500-7
references.pmid: 19509543
references.citation: J Reprod Fertil. 1988 Jan;82(1):219-25
references.pmid: 3339581
references.citation: J Ovarian Res. 2010 Oct 19;3:24
references.pmid: 20958993
references.citation: Cell Cycle. 2009 Jan 1;8(1):23-6
references.pmid: 19098432
references.citation: J Ultrasound Med. 2007 Jul;26(7):909-19
references.pmid: 17592054
references.citation: J Reprod Fertil. 1998 Nov;114(2):253-8
references.pmid: 10070355
references.citation: Poult Sci. 2004 Jun;83(6):911-6
references.pmid: 15206617
references.citation: Immunogenetics. 1996;44(3):212-7
references.pmid: 8662088
references.citation: Reprod Biol Endocrinol. 2003 Oct 07;1:67
references.pmid: 14613552
references.citation: Cancer Res. 2004 Mar 1;64(5):1655-63
references.pmid: 14996724
references.citation: Cancer Immunol Immunother. 2009 Mar;58(3):449-59
references.pmid: 18791714
references.citation: Environ Health Perspect. 1987 Aug;73:35-51
references.pmid: 3665870
references.citation: Eur J Gynaecol Oncol. 2002;23(6):533-6
references.pmid: 12556098
references.citation: Cancer Treat Res. 2009;149:353-91
references.pmid: 19763445
references.citation: Cancer Prev Res (Phila). 2009 Feb;2(2):114-21
references.pmid: 19174584
references.citation: Nat Med. 2005 Jan;11(1):63-70
references.pmid: 15619626
references.citation: Gynecol Oncol. 2001 Jun;81(3):373-9
references.pmid: 11371125
references.citation: Oncol Rep. 2011 Jan;25(1):49-56
references.pmid: 21109956
references.citation: Gynecol Oncol. 2007 Jan;104(1):192-8
references.pmid: 16942793
references.citation: Gynecol Oncol. 2009 Jun;113(3):362-9
references.pmid: 19321195
references.citation: Poult Sci. 2004 Apr;83(4):580-90
references.pmid: 15109055
references.citation: Br Poult Sci. 2003 Mar;44(1):6-21
references.pmid: 12737220
references.citation: Poult Sci. 2006 Feb;85(2):246-50
references.pmid: 16523622
references.citation: Gynecol Oncol. 2009 Oct;115(1):112-120
references.pmid: 19647308
references.citation: Am J Reprod Immunol. 2007 Apr;57(4):243-9
references.pmid: 17362385
references.citation: Gynecol Oncol. 2009 Jan;112(1):166-70
references.pmid: 18986688
references.citation: Reproduction. 2001 Jun;121(6):953-7
references.pmid: 11373182
references.citation: PLoS One. 2009 Jul 29;4(7):e6412
references.pmid: 19641607
references.citation: Int J Gynecol Cancer. 2010 Jul;20(5):738-44
references.pmid: 20973263
references.citation: Immunol Invest. 2006;35(3-4):251-77
references.pmid: 16916754
references.citation: Mod Pathol. 2009 Mar;22(3):393-402
references.pmid: 19060844
references.citation: Gynecol Oncol. 2006 Nov;103(2):673-8
references.pmid: 16797680